Intermediate-Size Patient Population Expanded Access Protocol of Verdiperstat in Patients With Multiple System Atrophy (MSA)
Latest Information Update: 22 Oct 2021
At a glance
- Drugs Verdiperstat (Primary)
- Indications Multiple system atrophy
- Focus Expanded access; Therapeutic Use
- Sponsors Biohaven Pharmaceuticals
- 22 Oct 2021 New trial record